BETA

Subject "4.60.08 Safety of products and services, product liability"

Dossiers (112)

Medical devices: annual overview of devices subject to the clinical evaluation consultation procedure (April 2021-June 2022)
New Legislative Framework for EU product legislation. Evaluation. Executive summary
New Legislative Framework for EU product legislation. Evaluation
Safety of toys. Evaluation. Executive Summary
Safety of toys. Evaluation
Further extension of the duration of the work programme for the systematic examination of all existing biocidal active substances
Making available on the market and use of biocidal products: including nitrogen generated from ambient air as an active substance in Annex I
Next steps towards greater patient safety by swiftly ensuring the availability of medical devices through a targeted transitional period
Gradual roll-out of Eudamed, information obligation in case of interruption of supply and transitional provisions for certain in vitro diagnostic medical devices
Date of application of the essential requirements for radio equipment
Assignment of Unique Device Identifiers for contact lenses
Charging receptacle and charging communication protocol for all the categories or classes of radio equipment capable of being recharged by means of wired charging
Regulatory technical standards for strong customer authentication and common and secure open standards of communication: correcting the Swedish language version
Provision of digital euro services by payment services providers incorporated in Member States whose currency is not the euro
Payment services in the internal market
Payment services and electronic money services in the Internal Market
Authorisation and supervision of medicinal products for human use and governing rules for the European Medicines Agency
Detergents and surfactants
Common rules promoting the repair of goods
Transitional provisions for certain medical devices and in vitro diagnostic medical devices
Frequency of complete re-assessments of notified bodies
Frequency of complete re-assessments of notified bodies
Revision of the Medical Devices Regulation – how to ensure the availability of medical devices
Payment services – amendment to the 90-day exemption for account access
Liability for defective products
Amending certain Directives as regards the establishment of the Single Market emergency instrument
Amending certain Regulations as regards the establishment of the Single Market emergency instrument
Cyber Resilience Act
Regulatory technical standards specifying the framework for cooperation and the exchange of information between competent authorities of the home and the host Member States in the context of supervision of payment institutions and electronic money institutions exercising cross-border provision of payment services
Biocidal products: including carbon dioxide generated from propane, butane or a mixture of both by combustion as an active substance in Annex I
Biocidal products: including potassium sorbate as an active substance in Annex I
Implementation of Directive 2009/48/EC of the European Parliament and of the Council on the safety of toys (Toy Safety Directive)
Transitional provisions for certain in vitro diagnostic medical devices and deferred application of requirements for in-house devices
Radio Equipment Directive: common charger for electronic devices
General Product Safety Regulation
European Digital Identity framework
Biocidal products: including citric acid as an active substance in Annex I
Resolution on the draft Commission implementing regulation approving carbendazim as an existing active substance for use in biocidal products of product-types 7 and 10
Making available on the market and use of biocidal products: amending Annexes II and III
Regulatory technical standards on the criteria for appointing central contact points within the field of payment services and on the functions of those central contact points. Corrigendum
Medical devices
Biocidal products: including powdered egg as an active substance in Annex I
Biocidal products: including honey as an active substance in Annex I
Biocidal products: including vinegar as an active substance in Annex I
Biocidal products: including Saccharomyces cerevisiae as an active substance in Annex I
Biocidal products: including concentrated apple juice as an active substance in Annex I
Biocidal products: including cheese as an active substance in Annex I
Biocidal products: including D-fructose as an active substance in Annex I
Regulatory technical standards on the criteria for appointing central contact points within the field of payment services and on the functions of those central contact points
Addressing product safety in the Single Market
Work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council
Motor vehicles insurance
Strong customer authentication and common and secure open standards of communication
Biocidal products: scientific criteria for the determination of endocrine-disrupting properties
Work programme for the systematic examination of all existing active substances contained in biocidal products
Compliance with and enforcement of Union harmonisation legislation on products
Safety features appearing on the packaging of medicinal products for human use
Contracts for the online and other distance sales of goods
Contracts for the supply of digital content
Safer healthcare in Europe: improving patient safety and fighting antimicrobial resistance
Appliances burning gaseous fuels
Personal protective equipment
Cableway installations
Information requirements for authorisation of biocidal products
Duration of the work programme for examination of existing biocidal active substances
Integrated parcel delivery market for the growth of e-commerce in the EU
Report from the Commission to the Council on the basis of Member States' reports on the implementation of the Council Recommendation (2009/C 151/01) on patient safety, including the prevention and control of healthcare associated infections
Payment services in the internal market
Consumer product safety
Market surveillance of products
Resolution on defective silicone gel breast implants made by French company PIP
Radio equipment: harmonisation of the laws of the Member States relating to the making available on the market
In vitro diagnostic medical devices
Medical devices
Electronic transactions in the internal market: electronic identification and trust services
Placing on the market of portable batteries and accumulators containing cadmium intended for use in cordless power tools, and of button cells with low mercury content
Pharmacovigilance: transparency and efficiency of the system. Directive
Pharmacovigilance: transparency and efficiency of the system. Regulation
Recreational craft and personal watercraft
Safety of toys
Revision of the "Package Travel Directive"
Revision of the General Product Safety Directive and market surveillance
Toy safety
Making available on the market and use of biocidal products
Patient safety, prevention and control of healthcare associated infections
Safety marking on consumer products
European professional card for services providers
Medicinal products for human use: prevention of the entry into the legal supply chain of falsified medicinal products
Medicinal products for human use: pharmacovigilance of products
Medicinal products for human use: pharmacovigilance of products
Safety of toys
Fire safety in hotels
Safety of toys
Resolution on the safety of products and particularly toys
Appliances burning gaseous fuels. Codification
Electro-medical equipment used in veterinary medicine: approximation of the laws of the Member States (repeal. Directive 84/539/EEC)
Common framework for the marketing of products
Requirements for accreditation and market surveillance relating to the marketing of products (repeal. Regulation (EEC) No 339/93)
Application of certain national technical rules to products lawfully marketed in another Member State
Advanced therapy medicinal products
Protection of consumers: placing on the market and use of pyrotechnic articles, in particular fireworks
Dangerous substances and preparations: cancerogens, mutagens and toxic, c/m/r category 1 or 2 (29th amend. Directive 76/769/EEC)
Health and environment: use of nonylphenol, nonylphenol ethoxylate and cement (26th amend. Directive 76/769/EEC)
Health implications of the Directive 93/42/EEC of 14 June 1993 on medical devices
Carriage by air: unification of certain rules, approval of the Montreal Convention
Protection of consumers: general product safety (rev. Directive 92/59/EEC)
Consumer protection: civil liability for defective products (direct. 85/374/EEC). Green paper
Child health protection: phthalates, dangerous substances, safety of toys (amend. Directives 76/769/EEC, 88/378/EEC)
Protection of consumers: liability for defective products (amend. Directive 85/374/EEC)
Safety requirements: cableway installations intended to carry passengers
Lifts: approximation of minimum requirements of security (repeal. Directives 84/528/EEC and 84/529/EEC)
Protection of consumers: liability of suppliers of services